| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Scilex Holding Co | 10%+ Owner | 960 SAN ANTONIO RD, PALO ALTO | /s/ Henry Ji, Scilex Holding Company, Chief Executive Officer and President | 23 Sep 2025 | 0001820190 |
| Scilex, Inc. | 10%+ Owner | 960 SAN ANTONIO RD, PALO ALTO | /s/ Henry Ji, Scilex, Inc., Chief Executive Officer and President | 23 Sep 2025 | 0002084647 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SMNR | Common Stock | 193,750,000 | 22 Sep 2025 | By Scilex, Inc. | F1, F2 | |||||
| holding | SMNR | Common Stock | 6,250,000 | 22 Sep 2025 | By Scilex Bio, Inc. | F3 | |||||
| holding | SMNR | Common Stock | 1,054,849 | 22 Sep 2025 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Represents shares of the Common Stock of the Issuer (f/k/a Denali Capital Acquisition Corp. ("Denali")) received pursuant to a business combination (the "Business Combination") which was effectuated in accordance with the terms of the Agreement and Plan of Merger, dated as of August 30, 2024 (as amended on April 16, 2025 and July 22, 2025), by and among the Issuer, Denali Merger Sub, Inc., a wholly owned subsidiary of the Issuer, and the company formerly known as Semnur Pharmaceuticals, Inc. ("Old Semnur"). Upon consummation of the Business Combination, the reporting entities' shares of the common stock of Old Semnur were exchanged for the shares of Common Stock of the Issuer reported in this row, based on an exchange ratio of 1.25 to 1. |
| F2 | Scilex, Inc. is the direct owner of the 193,750,000 shares of the Issuer's Common Stock set forth in this row. Scilex, Inc. is a subsidiary of Scilex Holding Company. |
| F3 | Scilex Bio, Inc. is the direct owner of 6,250,000 shares set forth in this row. Scilex Bio, Inc. is a majority-owned subsidiary of Scilex Holding Company. |
| F4 | Comprised of: (i) 542,361 shares of Common Stock issued pursuant to the Business Combination upon the exchange of 5,423,606 shares of Series A Preferred Stock of Old Semnur (each share of Series A Preferred Stock of Old Semnur was exchanged for one share of Series A Preferred Stock of the Issuer and 1/10th of a share of Common Stock of the Issuer), (ii) 500,000 shares of Common Stock purchased by Scilex Holding Company prior to the Business Combination, and (iii) 12,488 shares of Common Stock issued upon conversion of the Convertible Promissory Note previously issued by Denali Capital Acquisition Corp. to Scilex Holding Company, which was converted upon consummation of the Business Combination. |